Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.OPHTHA.2007.03.012PMID 17509688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.

  2006cited by this paper
• Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

  2006cited by this paper
• Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study

  2005cited by this paper
• 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.

  2005cited by this paper
• The Efficacy and Safety of Topical Brinzolamide and Dorzolamide When Added to the Combination Therapy of Latanoprost and a Beta-Blocker in Patients with Glaucoma

  2005cited by this paper
• Primary open-angle glaucoma.

  2004cited by this paper
• Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.

  2004cited by this paper
• Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

  2004cited by this paper
• Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure

  2004cited by this paper
• Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

  2003cited by this paper
• A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

  2003cited by this paper
• A short-term study of the additive effect of latanoprost 0.005% and brimonidine 0.2%.

  2003cited by this paper
• Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension

  2003cited by this paper
• Additive intraocular pressure lowering effect of various medications with latanoprost.

  2002cited by this paper
• The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

  2002cited by this paper
• Effectiveness and Safety of Brimonidine as Adjunctive Therapy for Patients With Elevated Intraocular Pressure in a Large, Open-label Community Trial

  2001cited by this paper
• Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.

  2001cited by this paper
• The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

  2000cited by this paper
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

  2000cited by this paper
• Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma

  2000cited by this paper
• The Ocular Hypertension Treatment Study: design and baseline description of the participants.

  1999cited by this paper
• Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow.

  1998cited by this paper
• Preferred practice patterns.

  1996cited by this paper
• The ocular hypertension treatment study.

  1994cited by this paper

• Efficacy and Drug Interactions of Glaucoma Medications: A Systematic Review and Component Network Meta-Analysis.

  2025cites this paper
• A Narrative Review of Pharmacotherapy of Glaucoma

  2024cites this paper
• Carbonic anhydrase inhibitors for the treatment of glaucoma

  2023cites this paper
• Topical Medication Therapy for Glaucoma and Ocular Hypertension

  2021cites this paper
• Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review.

  2021cites this paper
• Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study

  2021cites this paper
• A review of neuropsychiatric adverse events from topical ophthalmic brimonidine

  2020cites this paper
• Medical Ethics

  2020cites this paper
• Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis

  2019cites this paper
• Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma.

  2019cites this paper
• [Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)].

  2019cites this paper
• Brimonidine tartrate for the treatment of glaucoma

  2018cites this paper
• Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes

  2018cites this paper
• Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy

  2017cites this paper
• Medical Management of Glaucoma in the 21st Century from a Canadian Perspective

  2016cites this paper
• A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.

  2016cites this paper
• Medical Treatment: First-Line Agents, Monotherapy, and Combination Therapy

  2016cites this paper
• A COMPARATIVE STUDY OF THE EFFICACY AND ADVERSE EVENT PROFILE OF TOPICAL BRINZOLAMIDE WITH TOPICAL DORZOLAMIDE MONOTHERAPY IN PATIENTS OF PRIMARY OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION IN A NORTH-INDIAN POPULATION

  2014cites this paper
• klinisches Profil und Stellenwert von Prostaglandin-und Prostamid-Analoga in der antiglaukomatösen Therapie Mechanisms , Clinical Profile and Role of Prostaglandin and Prostamide Analogues in Antiglaucomatous Therapy

  2013cites this paper
• Wirkmechanismen, klinisches Profil und Stellenwert von Prostaglandin- und Prostamid-Analoga in der antiglaukomatösen Therapie

  2013cites this paper
• A Randomized, Prospective Study of Bimatoprost 0.01% or Travoprost/Timolol in Patients Previously Treated with Latanoprost and Timolol to Reduce Intraocular Pressure

  2013cites this paper
• Comparison of 24-Hour Intraocular Pressure Reduction Obtained with Brinzolamide/Timolol or Brimonidine/Timolol Fixed-Combination Adjunctive to Travoprost Therapy

  2013cites this paper
• How Ocular Surface Disease Impacts the Glaucoma Treatment Outcome

  2013cites this paper
• Intraocular Pressure-lowering Efficacy of Brinzolamide When Added to Travoprost/Timolol Fixed Combination as Adjunctive Therapy

  2012cites this paper
• Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues

  2012cites this paper
• [Pharmacological profile and clinical efficacy of brimonidine tartrate (AIPHAGAN(®) ophthalmic solution 0.1%)].

  2012cites this paper
• Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy

  2012cites this paper
• [Adjunctive therapy with brinzolamide in patients on travoprost treatment].

  2011cites this paper
• Medical management of glaucoma: Principles and practice

  2011cites this paper
• Update on the role of alpha-agonists in glaucoma management.

  2011cites this paper
• Drugs used in ocular treatment

  2011cites this paper
• Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure.

  2010cites this paper
• Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.

  2010cites this paper
• Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations

  2010cites this paper
• Choosing adjunctive glaucoma therapy

  2010cites this paper
• Medical Treatment: First Line Agents and Monotherapy

  2010cites this paper
• Aqueous pharmaceutical compositions, containing borate-polyol complexes

  2009cites this paper
• Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation.

  2009cites this paper
• CHAPTER 23 – Prostaglandins

  2009cites this paper
• Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.

  2009cites this paper
• Treatment of Glaucoma with the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

  2009cites this paper
• CHAPTER 24 – The adrenergic system and adrenergic agonists

  2009cites this paper
• Compositions pharmaceutiques ayant la biodisponibilité souhaitable

  2009cites this paper
• Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

  2008cites this paper
• Medical Management of Glaucoma

  2008cites this paper
• Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma

  2008cites this paper
• A review of additivity to prostaglandin analogs: fixed and unfixed combinations.

  2008cites this paper
• PG Adjunctive Therapies Comparative Studies : Topical Carbonic Anhydrase Inhibitors versus Other Agents Reference Comparing Agent

  2008cites this paper
• Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension

  2008influential citation
• Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database

  2008cites this paper
• Brinzolamide

  2008cites this paper
• Glaucoma: a review of adjunctive therapy and new management strategies

  2007cites this paper
• Brinzolamide: efficacy, safety and role in the management of glaucoma

  2007cites this paper